Prevalences of lumbosacral articulation anatomic variants identified on nuclear scintigraphy and transrectal ultrasonography of Selle Français Warmbloods, French Standardbred Trotters, and Thoroughbreds and agreement between results from the imaging modalities

OBJECTIVE To describe scintigraphic and transrectal ultrasonographic anatomic variants of the lumbosacral (LS) articulation in horses and to determine the agreement between results obtained with each imaging modality. ANIMALS 243 horses (81 Selle Français Warmbloods, 81 French Standardbred Trotters, and 81 Thoroughbreds). PROCEDURES A retrospective search of clinical records was conducted to identify horses that had undergone nuclear scintigraphy and transrectal ultrasonography of the LS region of the vertebral column between January 2016 and December 2019. Scintigraphic images were evaluated by 2 observers blinded to the other’s results for classification of LS articulation anatomic variants (scintigraphic type); intra- and interobserver agreement were determined. Ultrasonographic images were evaluated for classification of LS intervertebral symphysis anatomic variant (ultrasonographic grade) by 1 observer blinded to horses’ identities and scintigraphic findings; agreement analysis was performed between scintigraphic type and ultrasonographic grade. Descriptive and statistical analyses were performed to describe distribution of anatomic variants. RESULTS The scintigraphic classification system (scintigraphic type) had excellent intra- and interobserver agreement. Agreement between results for scintigraphic type and ultrasonographic grade was moderate (κ = 0.61; 95% CI, 0.52 to 0.70). Anatomic variants of the LS articulation were observed in all groups. The distribution of variants differed significantly among breeds but not sexes. CLINICAL RELEVANCE Anatomic variations of the LS articulation in horses must be known to avoid misinterpreting them as clinically meaningful findings. Further research is needed to determine potential relationships between these anatomic variants and LS lesions, their clinical manifestations, and their influence on athletic performance.

Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis

Often considered a rare disease, cardiac amyloidosis is increasingly recognized by practicing clinicians. The increased rate of diagnosis is in part due the aging of the population and increasing incidence and prevalence of cardiac amyloidosis with advancing age, as well as the advent of noninvasive methods using nuclear scintigraphy to diagnose transthyretin cardiac amyloidosis due to either variant or wild type transthyretin without a biopsy. Perhaps the most important driver of the increased awareness is the elucidation of the biologic mechanisms underlying the pathogenesis of cardiac amyloidosis which have led to the development of several effective therapies with differing mechanisms of actions. In this review, the mechanisms underlying the pathogenesis of cardiac amyloidosis due to light chain (AL) or transthyretin (ATTR) amyloidosis are delineated as well as the rapidly evolving therapeutic landscape that has emerged from a better pathophysiologic understanding of disease development.